Report Detail
Global HIV Integrase Strand Transfer Inhibitors (INSTI)
- RnM3475063 |
- 30 May, 2019 |
- Global |
- 131 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
According to this study, over the next five years the HIV Integrase Strand Transfer Inhibitors (INSTI) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in HIV Integrase Strand Transfer Inhibitors (INSTI) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of HIV Integrase Strand Transfer Inhibitors (INSTI) market by product type, application, key companies and key regions.
This study considers the HIV Integrase Strand Transfer Inhibitors (INSTI) value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Raltegravir
Elvitegravir Combination Drugs
Bictegravir Combination Drug
Cabotegravir
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Clinic
Drug Center
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Adcock Ingram Limited
Affine Formulations Limited
Aurobindo Pharma
Biocon Limited
Bristol-Myers Squibb
Cipla
Emcure Pharmaceuticals
Flamingo Pharmaceuticals Limited
Gilead Sciences
Hetero Drugs
IPCA Laboratories
Janssen Pharmaceutica (Johnson & Johnson)
LAURUS Labs
Medisist Pharma
Merck
Mylan
Ranbaxy Pharmaceuticals
Shanghai Desano Pharmaceuticals
ViiV Healthcare (GSK)
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global HIV Integrase Strand Transfer Inhibitors (INSTI) market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of HIV Integrase Strand Transfer Inhibitors (INSTI) market by identifying its various subsegments.
Focuses on the key global HIV Integrase Strand Transfer Inhibitors (INSTI) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the HIV Integrase Strand Transfer Inhibitors (INSTI) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of HIV Integrase Strand Transfer Inhibitors (INSTI) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2014-2024
- 2.1.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size CAGR by Region
- 2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Segment by Type
- 2.2.1 Raltegravir
- 2.2.2 Elvitegravir Combination Drugs
- 2.2.3 Dolutegravir and Its Combination Drug
- 2.2.4 Bictegravir Combination Drug
- 2.2.5 Cabotegravir
- 2.2.6 Other
- 2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
- 2.3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2014-2019)
- 2.3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type (2014-2019)
- 2.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Drug Center
- 2.4.4 Other
- 2.5 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
- 2.5.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application (2014-2019)
- 2.5.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Application (2014-2019)
3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) by Players
- 3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Players
- 3.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Players (2017-2019)
- 3.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Players (2017-2019)
- 3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 HIV Integrase Strand Transfer Inhibitors (INSTI) by Regions
- 4.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions
- 4.2 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth
- 4.3 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth
- 4.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth
- 4.5 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth
5 Americas
- 5.1 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Countries
- 5.2 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
- 5.3 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Countries
- 6.2 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
- 6.3 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) by Countries
- 7.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
- 7.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) by Countries
- 8.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
- 8.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast
- 10.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast (2019-2024)
- 10.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Regions
- 10.2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Type
- 10.8 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Application
11 Key Players Analysis
- 11.1 Adcock Ingram Limited
- 11.1.1 Company Details
- 11.1.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
- 11.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Adcock Ingram Limited News
- 11.2 Affine Formulations Limited
- 11.2.1 Company Details
- 11.2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
- 11.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Affine Formulations Limited News
- 11.3 Aurobindo Pharma
- 11.3.1 Company Details
- 11.3.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
- 11.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Aurobindo Pharma News
- 11.4 Biocon Limited
- 11.4.1 Company Details
- 11.4.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
- 11.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Biocon Limited News
- 11.5 Bristol-Myers Squibb
- 11.5.1 Company Details
- 11.5.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
- 11.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Bristol-Myers Squibb News
- 11.6 Cipla
- 11.6.1 Company Details
- 11.6.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
- 11.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Cipla News
- 11.7 Emcure Pharmaceuticals
- 11.7.1 Company Details
- 11.7.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
- 11.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Emcure Pharmaceuticals News
- 11.8 Flamingo Pharmaceuticals Limited
- 11.8.1 Company Details
- 11.8.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
- 11.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Flamingo Pharmaceuticals Limited News
- 11.9 Gilead Sciences
- 11.9.1 Company Details
- 11.9.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
- 11.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Gilead Sciences News
- 11.10 Hetero Drugs
- 11.10.1 Company Details
- 11.10.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
- 11.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Hetero Drugs News
- 11.11 IPCA Laboratories
- 11.12 Janssen Pharmaceutica (Johnson & Johnson)
- 11.13 LAURUS Labs
- 11.14 Medisist Pharma
- 11.15 Merck
- 11.16 Mylan
- 11.17 Ranbaxy Pharmaceuticals
- 11.18 Shanghai Desano Pharmaceuticals
- 11.19 ViiV Healthcare (GSK)
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on HIV Integrase Strand Transfer Inhibitors (INSTI) . Industry analysis & Market Report on HIV Integrase Strand Transfer Inhibitors (INSTI) is a syndicated market report, published as Global HIV Integrase Strand Transfer Inhibitors (INSTI) . It is complete Research Study and Industry Analysis of HIV Integrase Strand Transfer Inhibitors (INSTI) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
